JMP Securities maintains Cytokinetics stock with $78 target
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
Cloudflare price target raised to $180 from $135 at JMP Securities
JMP Securities raised the firm’s price target on Cloudflare (NET) to $180 from $135 and keeps an Outperform rating on the shares. Cloudflare ...
JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.